MedTrace Logo

Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)

NCT05882253 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2025-07-17

No results posted yet for this study

Summary

The researchers hope to learn if specific types of MRI software and techniques can help improve early prostate cancer detection at time of a MRI-guided prostate biopsy.

Conditions

Interventions

OTHER

Restricted Spectrum Imaging-Magnetic Resonance Imaging (RSI-MRI)

An advanced imaging software that supports improved prostate cancer detection and diagnosis

Sponsors & Collaborators

Principal Investigators

  • Michael A Liss, MD, PhD · University of California, San Diego

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-04
Primary Completion
2027-12-31
Completion
2028-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05882253 on ClinicalTrials.gov